{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:07:30Z","timestamp":1792156050694,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":860,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1002\/rth2.12408","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T06:46:18Z","timestamp":1594881978000},"page":"1024-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution"],"prefix":"10.1016","volume":"4","author":[{"given":"Inge","family":"Vangenechten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gadisseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12408_bb0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0015","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1538-7836.2011.04324.x","article-title":"von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein","volume":"9","author":"Schneppenheim","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0031-1300951","article-title":"Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS\u201013","volume":"38","author":"Chapman","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12408_bb0035","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and Type 2A von Willebrand disease: similar but different","volume":"42","author":"Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12408_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Budde","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0038-1647016","article-title":"Luminography\u2013an alternative assay for detection of von Willebrand factor multimers","volume":"60","author":"Schneppenheim","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1002\/rth2.12408_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.10.002","article-title":"Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update","volume":"42","author":"Schneppenheim","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1002\/rth2.12408_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1002\/rth2.12408_bb0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ajh.21739","article-title":"Analysis of von Willebrand factor structure by multimer analysis","volume":"85","author":"Ledford\u2010Kraemer","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1002\/rth2.12408_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12408_bb0085","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/rth2.12408_bb0090","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/rth2.12141","article-title":"Evaluation of a semi\u2010automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers","volume":"2","author":"Bowyer","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0095","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/ijlh.12869","article-title":"Evaluation of a new commercial method for von Willebrand factor multimeric analysis","volume":"40","author":"Crist","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12408_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22416","article-title":"Preclinical evaluation of a semi\u2010automated and rapid commercial electrophoresis assay for von Willebrand factor multimers","volume":"32","author":"Pikta","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1002\/rth2.12408_bb0105","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/hae.13261","article-title":"Evaluation of a new commercial von Willebrand factor multimer assay","volume":"23","author":"Favaloro","year":"2017","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12408_bb0110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ijlh.13107","article-title":"Semi\u2010automated von Willebrand factor multimer assay for von Willebrand disease: further validation, benefits and limitations","volume":"41","author":"Oliver","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12408_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4939-7196-1_36","article-title":"Laboratory testing for Von Willebrand Factor multimers","volume":"1646","author":"Oliver","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1002\/rth2.12408_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0125","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/asheducation-2014.1.524","article-title":"Clinical and laboratory diagnosis of VWD","volume":"2014","author":"Federici","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1002\/rth2.12408_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12408_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4939-7196-1_35","article-title":"Ristocetin\u2010Induced Platelet Aggregation (RIPA) and RIPA mixing studies","volume":"1646","author":"Frontroth","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1002\/rth2.12408_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179566","article-title":"Type 2B von Willebrand disease with or without large multimers: a distinction of the two sides of the disorder is long overdue","volume":"12","author":"Casonato","year":"2017","journal-title":"PLoS One"},{"key":"10.1002\/rth2.12408_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin\u2010induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0155","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1002\/rth2.12408_bb0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet\u2010 and collagen\u2010binding defects in type 2M von Willebrand disease","volume":"19","author":"Larsen","year":"2013","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12408_bb0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.24556","article-title":"Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease","volume":"92","author":"Favaloro","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1002\/rth2.12408_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/beha.2001.0137","article-title":"Type 2 von Willebrand disease causing defective von Willebrand factor\u2010dependent platelet function","volume":"14","author":"Meyer","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1002\/rth2.12408_bb0175","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.89.20.9846","article-title":"von Willebrand disease type B: a missense mutation selectively abolishes ristocetin\u2010induced von Willebrand factor binding to platelet glycoprotein Ib","volume":"89","author":"Rabinowitz","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1002\/rth2.12408_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1515\/cclm-2018-0059","article-title":"Verification of reference intervals in routine clinical laboratories: practical challenges and recommendations","volume":"57","author":"Ozarda","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/rth2.12408_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1067\/mlc.2001.111252","article-title":"Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization","volume":"137","author":"Casonato","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1002\/rth2.12408_bb0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V97.4.952","volume":"97","author":"Ribba","year":"2001","journal-title":"Blood"},{"key":"10.1002\/rth2.12408_bb0195","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.13742","article-title":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","volume":"15","author":"Doruelo","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12408_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"Favaloro","year":"2020","journal-title":"Haemophilia"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12408","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12408","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12408","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:20:07Z","timestamp":1762863607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2475037922020738"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12408","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}